DIAMPA LXR 12.5/2.5/1000MG TAB

DIAMPA LXR is a triple-action antidiabetic tablet combining empagliflozin, linagliptin, and metformin HCl. Each tablet contains 12.5mg empagliflozin, 2.5mg linagliptin, and 1000mg metformin HCl, working synergistically to help manage type 2 diabetes mellitus. Empagliflozin promotes glucose excretion through urine, linagliptin inhibits DPP-4 enzyme to enhance insulin secretion, and metformin reduces hepatic glucose production. This combination provides comprehensive glycemic control with cardiovascular and renal protective benefits. Suitable for patients requiring multi-drug therapy for optimal blood sugar management. Take as directed by your healthcare provider. Store in a cool, dry place away from moisture and direct sunlight.